These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8529284

  • 1. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.
    Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS.
    Cancer Chemother Pharmacol; 1996; 37(3):242-46. PubMed ID: 8529284
    [Abstract] [Full Text] [Related]

  • 2. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW.
    Cancer Res; 1992 Oct 01; 52(19):5373-8. PubMed ID: 1356617
    [Abstract] [Full Text] [Related]

  • 3. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
    Bacolod MD, Lin SM, Johnson SP, Bullock NS, Colvin M, Bigner DD, Friedman HS.
    Curr Cancer Drug Targets; 2008 May 01; 8(3):172-9. PubMed ID: 18473730
    [Abstract] [Full Text] [Related]

  • 4. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
    Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM.
    Cancer Chemother Pharmacol; 1999 May 01; 43(1):80-5. PubMed ID: 9923545
    [Abstract] [Full Text] [Related]

  • 5. Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).
    Dong Q, Johnson SP, Colvin OM, Bullock N, Kilborn C, Runyon G, Sullivan DM, Easton J, Bigner DD, Nahta R, Marks J, Modrich P, Friedman HS.
    Cancer Chemother Pharmacol; 1999 May 01; 43(1):73-9. PubMed ID: 9923544
    [Abstract] [Full Text] [Related]

  • 6. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
    Hilton J.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1867-72. PubMed ID: 6732847
    [Abstract] [Full Text] [Related]

  • 7. Busulfan therapy of central nervous system xenografts in athymic mice.
    Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS.
    Cancer Chemother Pharmacol; 1994 Jun 15; 35(2):127-31. PubMed ID: 7987988
    [Abstract] [Full Text] [Related]

  • 8. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
    Chresta CM, Crook TR, Souhami RL.
    Cancer Res; 1990 Jul 01; 50(13):4067-71. PubMed ID: 2354456
    [Abstract] [Full Text] [Related]

  • 9. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
    Cowman S, Fan YN, Pizer B, Sée V.
    BMC Cancer; 2019 Apr 03; 19(1):300. PubMed ID: 30943920
    [Abstract] [Full Text] [Related]

  • 10. Expression of the c-Myc protein in childhood medulloblastoma.
    Bruggers CS, Tai KF, Murdock T, Sivak L, Le K, Perkins SL, Coffin CM, Carroll WL.
    J Pediatr Hematol Oncol; 1998 Apr 03; 20(1):18-25. PubMed ID: 9482408
    [Abstract] [Full Text] [Related]

  • 11. Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.
    Friedman HS, Johnson SP, Colvin OM.
    Cancer Treat Res; 2002 Apr 03; 112():199-209. PubMed ID: 12481718
    [No Abstract] [Full Text] [Related]

  • 12. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K.
    Exp Hematol; 1993 Dec 03; 21(13):1640-7. PubMed ID: 8243566
    [Abstract] [Full Text] [Related]

  • 13. Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide.
    Murata M, Suzuki T, Midorikawa K, Oikawa S, Kawanishi S.
    Free Radic Biol Med; 2004 Sep 15; 37(6):793-802. PubMed ID: 15304255
    [Abstract] [Full Text] [Related]

  • 14. In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide.
    Moreb JS, Schweder M, Gray B, Zucali J, Zori R.
    Hum Gene Ther; 1998 Mar 20; 9(5):611-9. PubMed ID: 9551609
    [Abstract] [Full Text] [Related]

  • 15. c-Myc promoter activation in medulloblastoma.
    Siu IM, Lal A, Blankenship JR, Aldosari N, Riggins GJ.
    Cancer Res; 2003 Aug 15; 63(16):4773-6. PubMed ID: 12941792
    [Abstract] [Full Text] [Related]

  • 16. Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR.
    Futscher BW, Pieper RO, Dalton WS, Erickson LC.
    Cell Growth Differ; 1992 Apr 15; 3(4):217-23. PubMed ID: 1515367
    [Abstract] [Full Text] [Related]

  • 17. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
    Yamauchi T, Nowak BJ, Keating MJ, Plunkett W.
    Clin Cancer Res; 2001 Nov 15; 7(11):3580-9. PubMed ID: 11705880
    [Abstract] [Full Text] [Related]

  • 18. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro.
    Moreb JS, Maccow C, Schweder M, Hecomovich J.
    J Pharmacol Exp Ther; 2000 May 15; 293(2):390-6. PubMed ID: 10773007
    [Abstract] [Full Text] [Related]

  • 19. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
    Katsetos CD, Herman MM, Krishna L, Vender JR, Vinores SA, Agamanolis DP, Schiffer D, Burger PC, Urich H.
    Arch Pathol Lab Med; 1995 Aug 15; 119(8):734-43. PubMed ID: 7646332
    [Abstract] [Full Text] [Related]

  • 20. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC.
    Mutat Res; 1995 May 15; 336(3):269-78. PubMed ID: 7739615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.